Today is National PKU Awareness Day, and we stand with the PKU community to advance education, understanding, and action. Genetic testing plays a central role in that effort. After a PKU diagnosis, genetic testing helps individuals learn which genetic variants, sometimes called

This month at Alltrna, we have been taking time to say thank you. From the potluck that brought us together to the handwritten thank you cards that lifted up individual contributions. Gratitude is not limited to one month for us. It is part of who we are as one team and how we

Alltrna’s Senior Director of Strategy & Operations, Taleen Afeyan, gave a talk at the 2nd MENA Congress for Metabolism in Health and Disease 2025 titled, 𝘿𝙚𝙫𝙚𝙡𝙤𝙥𝙞𝙣𝙜 𝙩𝙍𝙉𝘼 𝙈𝙚𝙙𝙞𝙘𝙞𝙣𝙚𝙨 𝙩𝙤 𝙏𝙧𝙚𝙖𝙩 𝙇𝙞𝙫𝙚𝙧 𝙎𝙩𝙤𝙥 𝘾𝙤𝙙𝙤𝙣 𝘿𝙞𝙨𝙚𝙖𝙨𝙚. Her

Growth is better together. We launched Peer Mentoring Circles to create space for colleagues to share experiences, build skills, and strengthen Alltrna’s culture of trust, collaboration, and curiosity. These small groups offer an open, supportive environment to trade ideas,

Alltrna Chief Medical Officer Dr. Nerissa Kreher will join leaders from across the rare disease field for a panel titled, “𝘼 𝙉𝙚𝙬 𝙀𝙧𝙖 𝙛𝙤𝙧 𝙍𝙖𝙧𝙚 𝘿𝙞𝙨𝙚𝙖𝙨𝙚 𝘾𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝙏𝙧𝙞𝙖𝙡𝙨,” at the 𝗡𝗢𝗥𝗗 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲𝘀 & 𝗢𝗿𝗽𝗵𝗮𝗻 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀

Behind every breakthrough at Alltrna are people who are not only scientists, innovators, and colleagues, but also parents and caregivers. For Working Parent Awareness Day, our Culture Team hosted a panel where colleagues talked about how they balance family life with meaningful

95% of genetic rare diseases still don’t have therapies. On International Podcast Day, we’re amplifying the conversation about how to change that. In this podcast, Alltrna CEO Michelle Werner discusses how engineered tRNA medicines can restore missing protein production in

A huge congratulations to our colleagues at @FlagshipPioneer on 25 years of turning bold ideas into transformative medicines! At Alltrna, we’re building on this legacy of Bigger Leaps by pioneering tRNA medicines to unify treatment across Stop Codon Disease and redefine what’s

At Alltrna, curiosity sparks discovery, and Ayush Bhandari exemplifies that every day. As part of our Discovery Group’s pooled screening team, Ayush works at the frontier of tRNA science, using high-throughput methods and sequence engineering to explore hundreds of thousands of

We were proud to support the @NPKUA_Info's On the Horizon conference, joining families, advocates, and researchers who are driving therapeutic progress for PKU. Our team shared insights on the potential of tRNA medicines to address Stop Codon Disease, which encompasses the

.@DrugTargetRev spotlights Alltrna’s mutation-driven strategy to expand the reach of genetic medicine. By focusing on the shared genetic cause, rather than one disease at a time, our tRNA therapeutic approach can accelerate rare disease drug development. The article details how

Alltrna today announced the appointment of Dave Hava as Chief Scientific Officer. Dave combines deep scientific rigor with a proven ability to translate breakthrough science into transformative medicines. His leadership and previous experience in developing new therapeutics for

We’re pleased to share that Alltrna will present at the International Congress of Inborn Errors of Metabolism (ICIEM 2025), taking place September 2-6 in Kyoto, Japan. See below for more info on our oral presentation (Abstract #11395), titled, “𝘵𝘙𝘕𝘈 𝘢𝘵 𝘵𝘩𝘦

Alltrna volunteers spent our annual #DayofService with Cradles to Crayons, helping provide essential items to children living in low-income and homeless situations. Proud to support @c2cboston’s mission to #EndClothingInsecurity: https://t.co/6dX6D5rZGs #WeAreAlltrna

For #RNADay, we’re spotlighting the therapeutic potential of tRNA to move beyond the one-gene, one-disease, one-drug paradigm and scale genetic medicine for thousands of rare diseases. While messenger RNA (mRNA) carries the genetic instructions, transfer RNA (tRNA) makes them

July is Disability Pride Month, a global celebration born from the signing of the Americans with Disabilities Act on July 26, 1990, and a reminder that disability is a natural and valuable part of human diversity. At Alltrna, accessibility is not a project – it is woven into our

Earlier this month we took a moment collectively to recharge, so we could return to work with fresh perspectives. From exploring Croatia, Greece, and the UK to catching New England breezes, the Alltrna team found inspiration in every corner of the map. At Alltrna, curiosity

Raiders of the Lost Codon: Part 2. The treasure hunt for therapeutic #tRNA continues. In this new Advancing RNA article, Alltrna CEO Michelle Werner unpacks what it takes to evolve an ancient molecule into a modern medicine—and why engaging patient communities early is key to